Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
140 participants
INTERVENTIONAL
2002-05-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
2. To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Since stress is a factor in the development of many health conditions, a further understanding of the mechanisms of the RR should be developed. The project is designed to determine how the RR can improve the quality of life that has been adversely affected by stress.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Molecular Processes of the Relaxation Response in Older Adults
NCT00179569
The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults
NCT00179530
Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients
NCT00179543
The Relaxation vs. Retreat Study
NCT01857830
Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease
NCT06210035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
2. To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Since stress is a factor in the development of many health conditions, a further understanding of the mechanisms of the RR should be developed. The project is designed to determine how the RR can improve the quality of life that has been adversely affected by stress.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
relaxation response- meditation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age:18-49 years
* able to read and understand English
* able to attend al study visits
* access to a telephone (to schedule visits)
Exclusion Criteria
* asthma
* current use of any prescription or psychoactive medications or supplements
* either:
1. no prior experience with RR eliciting techniques
2. at least 3 years of regular RR elicitation (at least 20 min/day)
* BMI \>30
* exhaled nitric oxide levels \>60 ppb
* abnormal lab values (Hct \<32,creatinine \>1.3, glucose \>200
* pregnancy
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Herbert Benson, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth-Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H75-CCH-123424
Identifier Type: -
Identifier Source: secondary_id
H75-CCH-119124
Identifier Type: -
Identifier Source: secondary_id
2001P001747
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.